By Sola Ogundipe
A research team from the university of Manchester’s Paterson Institute for Cancer Research has identified a molecular flag that will help doctors predict which patients will respond best to complementary hormone therapy with tamoxifen.
The research, funded by the charity Breakthrough Breast Cancer and published in Plos One, looked at the connective tissue surrounding the tumour, which is known to send signals that help the cancer to grow.
The team, part of the Manchester Cancer Research Centre, found that
fibroblast cells — the cells that make up connective tissue in our
bodies -differ in their characteristics from patient to patient and can give clues about tamoxifen treatment response
Tamoxifen — used alongside traditional chemotherapy and radiotherapy
– blocks the female hormone estrogen that, in certain breast cancers, is required by the tumour to grow and it has been shown to improve cancer survival rates by up to one third.
However, about one third of patients with the appropriate type of breast cancer — known as estrogen receptor positive breast cancer –do not respond to tamoxifen or develop resistance to the drug.
Estrogen receptor positive breast cancer is the most common form of
the disease accounting for 70 percent of cases.
When used alongside traditional cancer therapies, Tamoxifen has been shown to be highly effective in some breast cancer patients, but, in a third of cases, the result has not been encouraging.
Scientists hope to predict which patients will respond to tamoxifen,and those who won’t, so the correct treatment is provided instantly which will improve disease outcomes.
They analysed tissue samples from 564 women with invasive breast
cancer, some of whom were given tamoxifen and some who weren’t; this allowed us to make a comparison between treatment responses.
They discovered that women who had low levels of a protein known as
pERK in their cancer-associated fibroblasts did not respond to
tamoxifen. Testing patients for the pERK flag could help doctors
determine whether tamoxifen is an appropriate treatment for their
patient or whether alternative therapies should be explored, so saving time and money.
The researchers now plan to further study molecular flags that are characteristic for cancer-associated fibroblasts.
Understanding how fibroblasts help the tumour to grow will allow the development of new strategies to block their harmful signals and overcome drug resistance.
4 types of breast cancer identified
A comprehensive study has categorized breast cancer into four types, already leading to new ideas on how to treat the different strains.
Scientists are now a step closer to understanding the genetic origins of the four major subtypes of breast cancer.
According to Nature, the study is part of a project that includes
similar studies of lung and colon cancer.
A consortium of researchers analysed tumours from 825 patients, using six different technologies to examine subsets of the tumours for various defects.
The four main subtypes confirmed by the study are luminal A, luminal B, HER2-enriched and basal-like.
One key finding shows that one of the subtypes is genetically more
similar to ovarian tumours than to other breast cancer tumours.
Patients with that specific mutation, categorized as basal-like, may benefit from the same type of chemotherapy used to treat ovarian cancer, the researchers said.
Cancer patients with luminal A had much better prognoses than those
with luminal B, which could help doctors understand when to treat
patients more aggressively.
And researchers are planning a new clinical trial based on the
findings for HER2 patients, who often — but not always — respond
well to a drug called Herceptin, allowing a more targeted group to get the drug (and others, who may not respond to it, to avoid it).
Comments are moderated. Please keep them clean and brief.
Headlines Newsview all
Without fear that they are clerics, some members of task-force working with the Enugu State Housing Corporation, allegedly dealt with four priests, beating them mercilessly. The ... Full story
Nemesis has finally caught up with an upcoming Nollywood actor and his wife as they are currently in police custody for selling their two-year-old son, ... Full story
In this interview with STEPHEN UKANDU, one of the oldest traditional rulers in Igbo land, His Royal Majesty, Eze Isaac Ikonne, the Enyi 1 of ... Full story
Rate this article
- Video Footage Of 2nd Jos Bomb Blast
- Listen To Leaked Call Of Jim Iyke Cursing Out Emma Agu
- Wale Expected Back In Nigeria Soon To Release A Track With Olamide
7-men Nigerian music group led by Don Jazzy, The Mavins have touched down in Ghana at the Kotoka International Airport this morning for tomorrow's Tigo ...
Nollywood actress, Funke Akindele, is one lady that cannot be easily seen because she has been moving from one location shoot to the other couple ...
A woman at the Isolo area of Lagos, delivered a baby with beads from the womb 11 months after pregnancy. Father of the baby and ...
The sourness in friendship between friends of Nollywood industry, Ghanaian thespians, John Dumelo and Yvonne Nelson is seriously heated up as John Dumelo has revealed ...
Nollywood actor, Von Apochi, is set to make his first movie appearance after a deadly fire accident he was involved in that almost claimed his ...
There is a recent welcomed development in the Nigeria police sector, as the Inspector-General of Police (IGP), Solomon Arase, on Thursday made some new orders ...
The Flying Eagles have been rated the youngest team heading to the FIFA U20 World Cup in New Zealand. The competition will hold from May 30 ... Full story
Eldest son of veteran actor Femi Robinson who passed on, Wednesday, at the age of 75, Wole Robinson has described his late father as “a ... Full story